User profiles for Sikhulile Moyo

Sikhulile Moyo

Botswana-Harvard AIDS Institute
Verified email at bhp.org.bw
Cited by 8227

[HTML][HTML] Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers… - Nature, 2022 - nature.com
The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves.
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …

[HTML][HTML] Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges

…, T Mogashoa, L Mupfumi, S Moyo… - Tuberculosis research …, 2018 - hindawi.com
Mycobacterium tuberculosis drug resistance is a threat to global tuberculosis (TB) control.
Comprehensive and timely drug susceptibility determination is critical to inform appropriate …

Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey

…, KE Wirth, MP Holme, J Makhema, S Moyo… - The lancet HIV, 2016 - thelancet.com
Background HIV programmes face challenges achieving high rates of HIV testing and treatment
needed to optimise health and to reduce transmission. We used data from the Botswana …

Impact of sampling density on the extent of HIV clustering

V Novitsky, S Moyo, Q Lei, V DeGruttola… - AIDS research and …, 2014 - liebertpub.com
Identifying and monitoring HIV clusters could be useful in tracking the leading edge of HIV
transmission in epidemics. Currently, greater specificity in the definition of HIV clusters is …

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile

…, K Maswabi, G Ajibola, S Moyo… - Science translational …, 2019 - science.org
Neonatal HIV-1 infection is associated with rapidly progressive and frequently fatal immune
deficiency if left untreated. Immediate institution of antiretroviral therapy (ART), ideally within …

Continued emergence and evolution of Omicron in South Africa: New BA. 4 and BA. 5 lineages

…, C Scheepers, E Wilkinson, K Subramoney, S Moyo… - MedRxiv, 2022 - medrxiv.org
South Africa’s fourth COVID-19 wave was driven predominantly by three lineages (BA.1, BA.2
and BA.3) of the SARS-CoV-2 Omicron variant of concern. We have now identified two …

[HTML][HTML] Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa

…, E Wilkinson, K Subramoney, Z Makatini, S Moyo… - Nature medicine, 2022 - nature.com
Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth …

Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa

…, J Kinsman, R Kwasa, J Maridadi, TM Moroka, S Moyo… - AIDS care, 2007 - Taylor & Francis
Adherence levels in Africa have been found to be better than those in the US. However around
one out of four ART users fail to achieve optimal adherence, risking drug resistance and …

[HTML][HTML] An early warning system for emerging SARS-CoV-2 variants

…, JA Leite, YS Leo, GM Leung, M Marklewitz, S Moyo… - Nature medicine, 2022 - nature.com
Global sequencing and surveillance capacity for SARS-CoV-2 must be strengthened and
combined with multidisciplinary studies of infectivity, virulence and immune escape, in order …

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during …

…, E van Widenfelt, C Moffat, S Moyo… - Journal of Infectious …, 2011 - academic.oup.com
Sikhulile Moyo , Sikhulile Moyo … Hughes, Shahin Lockman, Jean Leidner, Erik van Widenfelt,
Claire Moffat, Sikhulile Moyo, Joseph Makhema, Max Essex, Roger L. Shapiro, Increased …